NKAP mediates the tumorigenesis of human NB cells by inhibited proliferation and promoted apoptosis through activating the PI3K/AKT signaling pathways, and the expression of NKAP may act as a novel biomarker for predicting recurrence and chromosome 11q deletion in patients with NB. This evidence concerns the gene NKAP and neuroblastoma.